Inhibition of PI3K/AKT signaling by NVP-BKM120 promotes ABT-737-induced toxicity in established and primary cultured glioblastoma cells

被引:0
|
作者
Jane, Esther P. [1 ]
Premkumar, Daniel R. [1 ]
Morales, Alejandro [1 ]
Foster, Kimberly A. [1 ]
Pollack, Ian [1 ]
机构
[1] Univ Pittsburgh, Pittsburgh, PA USA
关键词
D O I
10.1158/1538-7445.AM2014-5116
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
5116
引用
收藏
页数:1
相关论文
共 50 条
  • [1] Inhibition of Phosphatidylinositol 3-Kinase/AKT Signaling by NVP-BKM120 Promotes ABT-737-Induced Toxicity in a Caspase-Dependent Manner through Mitochondrial Dysfunction and DNA Damage Response in Established and Primary Cultured Glioblastoma Cells
    Jane, Esther P.
    Premkumar, Daniel R.
    Morales, Alejandro
    Foster, Kimberly A.
    Pollack, Ian F.
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2014, 350 (01): : 22 - 35
  • [2] Effects of PI3K inhibitor NVP-BKM120 on overcoming drug resistance and eliminating cancer stem cells in human breast cancer cells
    Hu, Y.
    Guo, R.
    Wei, J.
    Zhou, Y.
    Ji, W.
    Liu, J.
    Zhi, X.
    Zhang, J.
    CELL DEATH & DISEASE, 2015, 6 : e2020 - e2020
  • [3] Effects of PI3K Inhibitor NVP-BKM120 on Acquired Resistance to Gefitinib of Human Lung Adenocarcinoma H1975 Cells
    梁一晨
    吴红革
    薛红建
    刘青
    石亮亮
    刘涛
    伍钢
    Current Medical Science, 2013, (06) : 845 - 851
  • [4] Effects of PI3K inhibitor NVP-BKM120 on acquired resistance to gefitinib of human lung adenocarcinoma H1975 cells
    Yi-chen Liang
    Hong-ge Wu
    Hong-jian Xue
    Qing Liu
    Liang-liang Shi
    Tao Liu
    Gang Wu
    Journal of Huazhong University of Science and Technology [Medical Sciences], 2013, 33 : 845 - 851
  • [5] Effects of PI3K inhibitor NVP-BKM120 on overcoming drug resistance and eliminating cancer stem cells in human breast cancer cells
    Y Hu
    R Guo
    J Wei
    Y Zhou
    W Ji
    J Liu
    X Zhi
    J Zhang
    Cell Death & Disease, 2015, 6 : e2020 - e2020
  • [6] Aspirin enhanced ABT-737-induced apoptosis via regulation of PI3K pathway in human cancer cells
    Zhang, Chong
    Feng, Lin-yi
    Shuai, Xiao-dan
    Xu, Ya-si
    Zhang, Dan
    Zhang, Da-yong
    Wang, Bao-ming
    Zhang, Li-huang
    Wang, Jun-bo
    Pan, Jian-ping
    Zhou, Hua
    Wang, Si-cong
    Lin, Neng-ming
    ACTA PHARMACOLOGICA SINICA, 2013, 34 : 19 - 19
  • [7] Effects of PI3K Inhibitor NVP-BKM120 on Acquired Resistance to Gefitinib of Human Lung Adenocarcinoma H1975 Cells
    Liang, Yi-chen
    Wu, Hong-ge
    Xue, Hong-jian
    Liu, Qing
    Shi, Liang-liang
    Liu, Tao
    Wu, Gang
    JOURNAL OF HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY-MEDICAL SCIENCES, 2013, 33 (06) : 845 - 851
  • [8] Blockade Efficacy of MEK/ERK-Dependent Autophagy Enhances PI3K/Akt Inhibitor NVP-BKM120's Therapeutic Effectiveness in Lung Cancer Cells
    Ren, Hui
    Chen, Mingwei
    CHEST, 2016, 149 (04) : 301A - 301A
  • [9] The Novel PI3K Kinase Inhibitor NVP-BKM120 Shows in Vitro and in Vivo Efficacy in Follicular Lymphoma by Disrupting Microenvironment Survival Signaling
    Matas-Cespedes, A.
    Rodriguez, V.
    Roue, G.
    Campo, E.
    Lopez-Guillermo, A.
    Colomer, D.
    Perez-Galan, P.
    EUROPEAN JOURNAL OF CANCER, 2012, 48 : S190 - S190
  • [10] Treatment with the PI3K inhibitor buparlisib (NVP-BKM120) suppresses the growth of established patient-derived GBM xenografts and prolongs survival in nude rats
    I. A. Netland
    H. E. Førde
    L. Sleire
    L. Leiss
    M. A. Rahman
    B. S. Skeie
    H. Miletic
    P. Ø. Enger
    D. Goplen
    Journal of Neuro-Oncology, 2016, 129 : 57 - 66